Novasep Expands and Opens Subsidiary in India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Novasep Expands and Opens Subsidiary in India



Novasep, a provider of separation sciences services and fine chemicals, is expanding its presence in India with the opening of Novasep Process Engineering Services, a part of its industrial business unit. The new office will enable Novasep to further serve industries in India producing functional and commodity food and feed ingredients, milk derivatives, and bio-based chemicals. Novasep will continue to sell biopharma chromatography equipment and associated processes in India.

Novasep India will continue to collaborate with the Nilsan Nishotech Systems, which has represented Novasep in India for more than 20 years. Nilsan Nishotech will remain the exclusive agent for Novasep for industrial biotech and biopharma purification processes and systems in India.

Source: Novasep

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here